Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single‐center long‐term follow‐up study

OBJECTIVES: Levodopa/carbidopa intrajejunal gel (LCIG) is an effective therapeutic strategy to overcome levodopa‐induced motor complications in advanced Parkinson's disease (PD). However, it requires invasive percutaneous endoscopic gastrojejunostomy (PEG‐J) and may be associated with serious a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rus, Tomaž, Premzl, Maša, Križnar, Nina Z., Kramberger, Milica G., Rajnar, Robert, Ocepek, Lidija, Pirtošek, Zvezdan, Trošt, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796727/
https://www.ncbi.nlm.nih.gov/pubmed/35903042
http://dx.doi.org/10.1111/ane.13675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796727/
https://www.ncbi.nlm.nih.gov/pubmed/35903042
http://dx.doi.org/10.1111/ane.13675

Ejemplares similares